What BTNX does

BTNX Inc. is a privately held Canadian biotechnology company founded in 1998 and headquartered in Pickering, Ontario. The company specializes in the research, development, and manufacture of rapid in-vitro diagnostic (IVD) tests and point-of-care diagnostics using lateral flow immunoassay technology, distributing products globally under the Rapid Response™ brand. BTNX also operates as a certified Original Equipment Manufacturer (OEM) of rapid diagnostic tests for third-party brands.

The company's product portfolio spans nine major diagnostic categories with 50+ SKUs: harm reduction test strips (fentanyl, xylazine, medetomidine, nitazene, benzodiazepine); infectious disease tests (HIV, Hepatitis A/B/C, COVID-19, influenza, strep A, RSV, and 30+ other pathogens); cancer screening via fecal immunochemical tests; cardiac markers (D-Dimer, CRP, troponin); fertility testing; urinalysis; glucose monitoring; wearable ECG patches (S-Patch); and drug/alcohol screening. Complementary software products include HL7/POCT1-A2 compliant data management systems, the RapidReader App, and the DASH Rapid PCR System. Products carry accuracy ratings of 98-99.9% with results typically available in 5-15 minutes.

BTNX generates revenue through direct product sales (B2B to healthcare facilities and B2C via e-commerce at btnx.com), OEM contract manufacturing, and multi-tier distributor networks spanning dozens of countries. Pricing follows a unit-pricing model with kit sizes from 5 to 100 tests (e.g., $15 CAD for fentanyl 10-pack; $100 CAD for 100-pack). The company holds ISO 13485:2016 certification, FDA clearances, Health Canada authorizations, and CE Marking, and is led by CEO and founder Iqbal Sunderani.

Name

BTNX

Legal name

BTNX Inc.

Website

https://btnx.com

Company type

Private

Founded year

1998

Operating status

Operating

Headcount range

101–250 employees

Short description

BTNX Inc. is a Canadian biotechnology company that develops and manufactures rapid point-of-care in-vitro diagnostic tests under the Rapid Response brand, serving healthcare facilities, government health agencies, harm reduction programs, and consumers across more than 35 disease categories globally.

Ownership category

akta.pro rank

Product category

In-Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

Home Diagnostic & Self-Test OTC Kits (HLAIADAO)

Keywords

• Rapid diagnostic tests
• In-vitro diagnostics
• Point-of-care testing
• Lateral flow immunoassay
• Harm reduction test strips

Headquarters

HQ city

Markham

HQ country

Canada

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Rapid Diagnostic Test Products: BTNX generates revenue through the sale of rapid point-of-care diagnostic test kits across multiple categories including infectious diseases, drug screening, fertility testing, urinalysis, glucose monitoring, cardiac markers, tumor markers, and harm reduction products. Products are sold in various formats (cassettes, strips, kits) to healthcare facilities and consumers.
2. OEM Manufacturing: BTNX operates as a certified Original Equipment Manufacturer (OEM) of rapid diagnostic tests, manufacturing products for other brands and companies under contract.
3. Distribution and Resale: Revenue generated through a network of distributors who resell BTNX products to end customers globally, with the company focusing on providing high-quality products at competitive pricing to increase distributor margins.

Pricing tiers

Go-to-market motion2 records

Distribution channels5 records

Marketing channels5 records

Core offering

BTNX researches, develops, and manufactures advanced in-vitro diagnostic (IVD) rapid test kits and point-of-care diagnostic devices sold under the 'Rapid Response' brand. Its catalog spans harm-reduction drug-checking strips, infectious disease panels, urinalysis, fertility, cardiac markers, glucose monitoring, tumor markers, and wearable ECG monitoring products, with both professional-use and at-home self-test SKUs. The company also operates as an OEM contract manufacturer and runs a consumer-direct e-commerce channel (btnx.com) in Canada and a U.S. distribution partnership with Lochness Medical.

Product overview

BTNX is a biotechnology company and world leader in rapid, point-of-care diagnostics. The company distributes its products under the Rapid Response™ brand and operates as a certified OEM of rapid diagnostic tests. BTNX offers a comprehensive portfolio of diagnostic products organized into major categories: (1) Harm Reduction products including Fentanyl, Xylazine (2.0), Medetomidine, Nitazene, and Benzodiazepine test strips for street drug checking; (2) Infectious Diseases tests covering HIV (3 formats including 4th generation), Hepatitis A/B/C, COVID-19 (home and professional), Influenza A&B, Strep A, RSV, and over 35 other pathogens; (3) Cancer Screening via Fecal Immunochemical Test (FIT) for colorectal cancer; (4) Glucose Monitoring including blood glucose meters and HbA1c analyzers; (5) Cardiac Markers for D-Dimer, CRP, and cardiac proteins; (6) Fertility Testing for pregnancy, ovulation, male fertility, and menopause; (7) Urinalysis products including reagent strips, analyzers, and UTI tests; (8) Wearable Monitoring Devices including S-Patch ECG patches; and (9) Drug Screening, Alcohol Testing, and Spiked Drink Detection products. The company also develops IT systems for point-of-care diagnostic data management using HL7/POCT1-A2 compliant software. Products are manufactured in ISO 13485:2016 certified facilities with global regulatory approvals including FDA, CE Mark, and Health Canada authorization.

Differentiator

Problem solved

Functional benefit

Brands

• Rapid Response: The primary brand under which BTNX distributes its diagnostic products including rapid test kits for drugs, infectious diseases, fertility, and other applications.

Products and services

• Fentanyl Test Strips (FYL)

Quantifiable outcome

• HIV 1/2 Test Cassette: 99.9% accuracy, 10 minutes to result
• +5 more outcomes

Named customers4 records

Segments5 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Eight partnerships are on record, tiered core, major and minor.

• IntertekcoreOthersIntertek is BTNX's ISO auditing company, conducting annual audits to certify BTNX's quality management system under ISO 13485:2016 standards.
• Lochness MedicalmajorChannel Partner/ Reseller/ DistributorLochness Medical serves as BTNX's partner for US customers, directing US buyers to purchase BTNX products including fentanyl test strips, xylazine test strips, and other harm reduction products through their platform.
• Premier Health AlliancemajorChannel Partner/ Reseller/ DistributorBTNX is a premier supplier to Premier's healthcare alliance network, which brings together healthcare facilities and suppliers meeting rigorous standards for quality products.
• Vancouver Coastal Health AuthoritymajorChannel Partner/ Reseller/ DistributorVancouver Coastal Health Authority offers Rapid Response Fentanyl Strips at their overdose prevention and supervised consumption sites and in their take-home drug testing kits in British Columbia.
• City of HamiltonmajorChannel Partner/ Reseller/ DistributorCity of Hamilton's Drug Checking Program includes Rapid Response Fentanyl Test Strips and Xylazine Test Strips as part of their harm reduction services.
• Canadian Aboriginal and Minority Supplier Council (CAMSC)minorOthersBTNX is a certified member of CAMSC as a business majority owned, managed, and controlled by visible minorities.
• Ajax-Pickering Board of TrademinorOthersBTNX is a member of the Ajax-Pickering Board of Trade, the local business chamber in Pickering, Ontario.
• Advanced Manufacturing PartnerscoreTechnology or IntegrationBTNX builds strategic alliances with the most advanced innovative manufacturing facilities to accomplish efficient product development and sourcing infrastructure.

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

Market position

Competitive moat5 records

Key risks5 records

Key highlights6 records

Customer concentration

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about BTNX